Effects of acute and chronic ibopamine administration on resting and exercise hemodynamics, plasma catecholamines and functional capacity of patients with chronic congestive heart failure
- 1 September 1992
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 70 (6) , 629-634
- https://doi.org/10.1016/0002-9149(92)90203-b
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Dopaminergic Receptor Mechanisms Modulating the Renin-Angiotensin System and Aldosterone SecretionJournal of Cardiovascular Pharmacology, 1989
- The Long-Term Efficacy of Ibopamine in Treating Patients with Severe Heart FailureJournal of Cardiovascular Pharmacology, 1989
- Long-Term Therapy of Chronic Congestive Heart Failure with IbopamineJournal of Cardiovascular Pharmacology, 1989
- Lack of tolerance development during chronic ibopamine administration to patients with congestive heart failureCardiovascular Drugs and Therapy, 1988
- Effects of long-term therapy with oral ibopamine on resting hemodynamics and exercise capacity in patients with heart failure: relationship to the generation of N-methyldopamine and to plasma norepinephrine levels.Circulation, 1986
- Dopamine receptors: applications in clinical cardiology.Circulation, 1985
- The Dopamine Congener, Ibopamine, in Congestive Heart FailureJournal of Cardiovascular Pharmacology, 1984
- Hemodynamic Effects of Ibopamine in Patients with Idiopathic Congestive CardiomyopathyJournal of Cardiovascular Pharmacology, 1983
- Noninvasive Evaluation of the Effects of Oral Ibopamine (SB 7505) on Cardiac and Renal Function in Patients with Congestive Heart FailureJournal of Cardiovascular Pharmacology, 1982
- Newer catecholamines for treatment of heart failure and shock: An update on dopamine and a first look at dobutamineProgress in Cardiovascular Diseases, 1977